HHS secretary Robert F. Kennedy, Jr. announced the termination of approximately $500 million in mRNA vaccine contracts, indicating a halt in federal investment for mRNA technology. Kennedy stated that mRNA vaccines are ineffective against upper respiratory illnesses and may cause viruses to mutate. His claims lack supporting evidence. BARDA has canceled 22 investments in mRNA vaccine development based on these assertions. The medical community has condemned this decision, while vaccine skeptics have praised it. Experts suggest that mRNA production methods are crucial for rapid vaccine development during pandemics.
"After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology proposes more risk than benefits for these respiratory viruses," Kennedy said.
"This is beyond shortsighted," Osterholm said.
Collection
[
|
...
]